Cargando…
Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
BACKGROUND: The ANZACS‐QI Cardiac Implanted Device Registry (ANZACS‐QI DEVICE) collects nationwide data on cardiac implantable electronic devices in New Zealand (NZ). We used the registry to describe contemporary NZ use of implantable cardioverter defibrillator (ICD) and cardiac resynchronization th...
Autores principales: | Foo, Fang Shawn, Lee, Mildred, Looi, Khang‐Li, Larsen, Peter, Clare, Geoffrey C., Heaven, David, Stiles, Martin K., Voss, Jamie, Boddington, Dean, Jackson, Rod, Kerr, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011834/ https://www.ncbi.nlm.nih.gov/pubmed/32071634 http://dx.doi.org/10.1002/joa3.12244 |
Ejemplares similares
-
Editorial to implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Minamiguchi, Hitoshi
Publicado: (2019) -
Postdischarge outcome after Takotsubo syndrome compared with patients post-ACS and those without prior CVD: ANZACS-QI 19
por: Looi, Jen-Li, et al.
Publicado: (2018) -
The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55)
por: Chan, Daniel ZL., et al.
Publicado: (2020) -
Prehospital identification of ST-segment elevation myocardial infarction and mortality (ANZACS-QI 61)
por: Liao, Becky Yi-Wen, et al.
Publicado: (2022) -
The Impact of a National COVID-19 Lockdown on Acute Coronary Syndrome Hospitalisations in New Zealand: an ANZACS-QI study
por: Chan, D., et al.
Publicado: (2021)